Go
Sort by:
titlesubmit dateissue date
Order:
ascendingdescending
Results:
51020406080100
Update
Now showing items 1-17 of 17
A population-based study of mortality due to muscular dystrophies across a 36-year period in Spain
Artículo
A Small Non-Coding RNA Modulates Expression of Pilus-1 Type in Streptococcus pneumoniae
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice
Ceramide Composition in Exosomes for Characterization of Glioblastoma Stem-Like Cell Phenotypes.
Clonal dynamics in osteosarcoma defined by RGB marking
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma
EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway.
Frequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype-phenotype relationships.
Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Necesidades de formación en enfermedades raras para atención primaria
Remission of Spontaneous Canine Tumors after Systemic Cellular Viroimmunotherapy
RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models
SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications
Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome
Systemic Treatment of Immune-Mediated Keratoconjunctivitis Sicca with Allogeneic Stem Cells Improves the Schirmer Tear Test Score in a Canine Spontaneous Model of Disease
The Transcription Factor FEZF1, a Direct Target of EWSR1-FLI1 in Ewing Sarcoma Cells, Regulates the Expression of Neural-Specific Genes.
Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma.
2021-09-052021-07-27
